Sort   by:  
 Page size 
UnknownComparing Patients with ZZ Versus SZ Alpha-1 Antitrypsin Deficiency: Findings from AlphaNet's Disease Management Program.
Not available
S-EPMC6373591 | biostudies-literature
UnknownQuality of Life and Mortality Outcomes for Augmentation Naive and Augmented Patients with Severe Alpha-1 Antitrypsin Deficiency.
Not available
S-EPMC10392875 | biostudies-literature
UnknownEnoxaparin augments alpha-1-antitrypsin inhibition of TMPRSS2, a promising drug combination against COVID-19.
Not available
S-EPMC8953970 | biostudies-literature
UnknownPhase 2 clinical trial of a recombinant adeno-associated viral vector expressing α1-antitrypsin: interim results.
Not available
S-EPMC3205788 | biostudies-literature
UnknownSmall-Molecule Inhibitors Targeting Topoisomerase I as Novel Antituberculosis Agents.
Not available
S-EPMC4914652 | biostudies-literature
UnknownHuman Treg responses allow sustained recombinant adeno-associated virus-mediated transgene expression.
Not available
S-EPMC3859421 | biostudies-literature
UnknownRationale and Design of the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis Study. Alpha-1 Protocol.
Not available
S-EPMC4627425 | biostudies-literature
Sort   by:  
 Page size